CN101143815A - The preparation method of felbinac - Google Patents
The preparation method of felbinac Download PDFInfo
- Publication number
- CN101143815A CN101143815A CNA2007100526680A CN200710052668A CN101143815A CN 101143815 A CN101143815 A CN 101143815A CN A2007100526680 A CNA2007100526680 A CN A2007100526680A CN 200710052668 A CN200710052668 A CN 200710052668A CN 101143815 A CN101143815 A CN 101143815A
- Authority
- CN
- China
- Prior art keywords
- felbinac
- reaction
- biphenyl
- preparation
- chloromethylation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 title claims abstract description 36
- 229960000192 felbinac Drugs 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 27
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 20
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 239000012043 crude product Substances 0.000 claims abstract description 11
- 239000007789 gas Substances 0.000 claims abstract description 10
- 238000003747 Grignard reaction Methods 0.000 claims abstract description 9
- 239000004305 biphenyl Substances 0.000 claims abstract description 9
- 235000010290 biphenyl Nutrition 0.000 claims abstract description 9
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims abstract description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000007265 chloromethylation reaction Methods 0.000 claims abstract description 8
- 238000001953 recrystallisation Methods 0.000 claims abstract description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 4
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims abstract description 4
- 230000007062 hydrolysis Effects 0.000 claims abstract description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 3
- 238000007670 refining Methods 0.000 claims abstract 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 22
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 4
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 claims description 4
- 239000007818 Grignard reagent Substances 0.000 claims description 2
- 150000004795 grignard reagents Chemical class 0.000 claims description 2
- DWYIPNAFTUBKSA-UHFFFAOYSA-N 1,1'-biphenyl;chloromethane Chemical compound ClC.C1=CC=CC=C1C1=CC=CC=C1 DWYIPNAFTUBKSA-UHFFFAOYSA-N 0.000 claims 1
- 239000007810 chemical reaction solvent Substances 0.000 claims 1
- 125000001033 ether group Chemical group 0.000 claims 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract description 3
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 231100000167 toxic agent Toxicity 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 239000012065 filter cake Substances 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical compound N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 description 4
- DMDPKUWXJUYFKO-UHFFFAOYSA-N 1,1'-biphenyl;hydrochloride Chemical compound Cl.C1=CC=CC=C1C1=CC=CC=C1 DMDPKUWXJUYFKO-UHFFFAOYSA-N 0.000 description 3
- -1 biphenyl chloride methane Chemical compound 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- QOWSWEBLNVACCL-UHFFFAOYSA-N 4-Bromophenyl acetate Chemical compound OC(=O)CC1=CC=C(Br)C=C1 QOWSWEBLNVACCL-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Natural products O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical class II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QEFMDEFYYCMJPY-UHFFFAOYSA-N 1-(chloromethyl)-2-phenylbenzene Chemical group ClCC1=CC=CC=C1C1=CC=CC=C1 QEFMDEFYYCMJPY-UHFFFAOYSA-N 0.000 description 1
- XVEFRABIRRNWFO-UHFFFAOYSA-N 2-(4-bromophenyl)butanoic acid Chemical compound CCC(C(O)=O)C1=CC=C(Br)C=C1 XVEFRABIRRNWFO-UHFFFAOYSA-N 0.000 description 1
- HSZCNGTZJWZAMF-UHFFFAOYSA-N 2-(4-phenylphenyl)acetonitrile Chemical compound C1=CC(CC#N)=CC=C1C1=CC=CC=C1 HSZCNGTZJWZAMF-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 208000004760 Tenosynovitis Diseases 0.000 description 1
- ZDVDCDLBOLSVGM-UHFFFAOYSA-N [chloro(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(Cl)C1=CC=CC=C1 ZDVDCDLBOLSVGM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- ZPAKPRAICRBAOD-UHFFFAOYSA-N fenbufen Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1C1=CC=CC=C1 ZPAKPRAICRBAOD-UHFFFAOYSA-N 0.000 description 1
- 229960001395 fenbufen Drugs 0.000 description 1
- 201000010603 frozen shoulder Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 239000003279 phenylacetic acid Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Images
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明涉及一种非甾体抗炎药联苯乙酸的制备方法,包括有以下依次步骤:1)合成联苯乙酸 以联苯为原料,通过氯甲基化、格氏反应、水解三步反应合成得联苯乙酸粗品;其中联苯、甲醛、磷酸、醋酸的摩尔比为1∶1∶3∶3,浓盐酸过量,并且在氯甲基化反应的同时向反应溶液中通入氯化氢气体,所述氯化氢气体的流量是1~50l/h;2)精制 上述步骤1)所得联苯乙酸粗品用30~70%(重量)乙酸溶液进行重结晶,得联苯乙酸纯品。本发明的有益效果在于:本发明反应过程中未使用、不产生毒性较大的化合物,对环境污染较小;原料均易于取得,价格便宜;所使用的设备也均为化工常用设备,操作简单,粗品总收率为38%~46%。The invention relates to a preparation method of a non-steroidal anti-inflammatory drug felbinac, which comprises the following steps in sequence: 1) synthesizing felbinac with biphenyl as a raw material, through three-step reactions of chloromethylation, Grignard reaction and hydrolysis The crude product of felbinac is synthesized; wherein the molar ratio of biphenyl, formaldehyde, phosphoric acid, and acetic acid is 1:1:3:3, concentrated hydrochloric acid is excessive, and hydrogen chloride gas is passed into the reaction solution while chloromethylation reaction, The flow rate of the hydrogen chloride gas is 1-50 l/h; 2) refining the crude felbinac obtained in the above step 1) with 30-70% (weight) acetic acid solution for recrystallization to obtain pure felbinac. The beneficial effect of the present invention is that: no toxic compounds are used in the reaction process of the present invention, and the environmental pollution is small; the raw materials are easy to obtain and the price is cheap; the equipment used is also common chemical equipment, and the operation is simple , The total yield of crude product is 38%~46%.
Description
技术领域 technical field
本发明涉及化学合成医药领域,特别是一种非甾体抗炎药联苯乙酸的制备方法。The invention relates to the field of chemical synthesis medicine, in particular to a preparation method of felbinac, a non-steroidal anti-inflammatory drug.
背景技术 Background technique
联苯乙酸是一种非甾体抗炎药,抗炎活性类似芬布芬,具有消炎镇痛和良好的透皮性能,其3%凝胶软膏广泛用于变形性关节炎、肩周炎、腱鞘炎、肌肉痛、软组织损伤等,具有较高的有效性和安全性。1986年9月日本Lederle公司以“Napageln”为商品名的软膏首次在日本上市,后来该药又以商品名“Traxamgel”在英国上市,目前该药已在十几个国家上市。根据国内外文献报导,联苯乙酸的合成路线有十余种,起始原料就有七种。例如:Felbinac is a non-steroidal anti-inflammatory drug. Its anti-inflammatory activity is similar to fenbufen. It has anti-inflammatory, analgesic and good transdermal properties. Its 3% gel ointment is widely used in osteoarthritis, frozen shoulder, Tenosynovitis, muscle pain, soft tissue injury, etc., have high effectiveness and safety. In September 1986, the Japanese Lederle Company's ointment under the trade name "Napageln" was launched in Japan for the first time. Later, the drug was launched in the UK under the trade name "Traxamgel". Currently, the drug has been listed in more than a dozen countries. According to domestic and foreign literature reports, there are more than ten synthetic routes of felbinac, including seven starting materials. For example:
(1)以对溴苯乙酸或对溴苯乙酸乙酯为原料可一步或两步合成联苯乙酸,以对溴苯乙酸为原料合成路线如下:(1) Taking p-bromophenylacetic acid or ethyl p-bromophenylacetic acid as a raw material can synthesize felbinac in one or two steps, and taking p-bromophenylacetic acid as a raw material synthetic route is as follows:
虽然工艺路线短、操作简单,但原料价格昂贵、不易取得,成本高;(2)以4-联苯基甲醛为原料,其中一条合成路线如下:Although the process route is short and easy to operate, the raw material is expensive, difficult to obtain, and the cost is high; (2) using 4-biphenyl formaldehyde as a raw material, one of the synthetic routes is as follows:
该路线操作复杂、产率低,且原料不易取得,成本高;The route is complex in operation, low in yield, difficult to obtain raw materials, and high in cost;
(3)以苯乙腈和联苯乙腈为原料,对环境污染大,对操作人员身体毒害也大,下面是以苯乙腈为原料的合成路线:(3) Taking phenylacetonitrile and biphenylacetonitrile as raw materials, it is very polluting to the environment, and it is also very harmful to the operator's body. Below is the synthetic route of taking phenylacetonitrile as raw material:
(4)以苯乙酸为原料,操作复杂、产率低,合成路线如下:(4) With phenylacetic acid as raw material, complicated operation and low yield, the synthetic route is as follows:
(5)因联苯价廉易得,通常是以联苯为原料合成联苯乙酸,目前合成路线就有五种,但大多操作复杂、污染大、反应过程中所用试剂难以制备,其中一条合成路线如下:(5) Because biphenyl is cheap and easy to obtain, biphenyl is usually used as raw material to synthesize felbinac. At present, there are five synthetic routes, but most of them are complicated to operate, pollute, and the reagents used in the reaction process are difficult to prepare. One of them synthesizes The route is as follows:
综上所述,以上各工艺路线均不适合进行企业生产。In summary, the above process routes are not suitable for enterprise production.
发明内容 Contents of the invention
本发明所要解决的技术问题是针对现有技术存在的不足而提供一种操作简单、污染小、成本低、易于取得原材料、适合企业生产的联苯乙酸的一种新的制备方法。The technical problem to be solved by the present invention is to provide a new preparation method of felbinac with simple operation, little pollution, low cost, easy access to raw materials and suitable for enterprise production in view of the deficiencies in the prior art.
本发明为解决上述提出的问题所采用的技术方案为:联苯乙酸的制备方法,包括有以下依次步骤:The technical scheme that the present invention adopts for solving the above-mentioned problem is: the preparation method of felbinac comprises the following steps in sequence:
1)合成联苯乙酸1) synthesis of felbinac
以联苯为原料,通过氯甲基化、格氏反应、水解三步反应合成得联苯乙酸粗品;其中联苯、甲醛、磷酸、醋酸的摩尔比为1∶1∶3∶3,浓盐酸过量,并且在氯甲基化反应的同时向反应溶液中通入氯化氢气体,所述氯化氢气体的流量是1~50L/h;Using biphenyl as raw material, the crude product of felbinac is synthesized through three steps of chloromethylation, Grignard reaction and hydrolysis; the molar ratio of biphenyl, formaldehyde, phosphoric acid and acetic acid is 1:1:3:3, concentrated hydrochloric acid Excessive, and feed hydrogen chloride gas into the reaction solution while chloromethylation reaction, the flow rate of the hydrogen chloride gas is 1~50L/h;
2)精制2) refined
上述步骤1)所得联苯乙酸粗品用30~70%(重量)乙酸溶液进行重结晶,得联苯乙酸纯品。The crude product of felbinac obtained in the above step 1) is recrystallized with 30-70% (weight) acetic acid solution to obtain pure felbinac.
按上述方案,所述的步骤1)中氯甲基化所得联苯氯甲烷用环已烷进行重结晶。According to the above scheme, the biphenyl chloride methane obtained by the chloromethylation in the step 1) is recrystallized with cyclohexane.
按上述方案,所述的步骤1)中格氏反应以溴乙烷引发格氏试剂生成。According to the above scheme, the Grignard reaction in the step 1) triggers the generation of the Grignard reagent with bromoethane.
按上述方案,所述的步骤1)中格氏反应所用溶剂为乙醚或者四氢呋喃。According to the above scheme, the solvent used for the Grignard reaction in the step 1) is diethyl ether or tetrahydrofuran.
本发明制备联苯乙酸的方法,合成路线如下:The present invention prepares the method for felbinac, and synthetic route is as follows:
通入氯化氢气体有利于提高联苯氯甲烷的产率;用环已烷重结晶联苯氯甲烷,可减少格氏反应中副产物的生成;以溴乙烷引发格氏反应,降低了反应温度,缩短了反应时间,其红外光谱及核磁共振谱见附图1~3。Feeding hydrogen chloride gas helps to improve the yield of biphenyl chloride; recrystallization of biphenyl chloride with cyclohexane can reduce the generation of by-products in the Grignard reaction; triggering the Grignard reaction with bromoethane reduces the reaction temperature , shortened the reaction time, its infrared spectrum and nuclear magnetic resonance spectrum are shown in accompanying drawings 1-3.
本发明的有益效果在于:The beneficial effects of the present invention are:
本发明反应过程中未使用、不产生毒性较大的化合物,对环境污染较小;原料均易于取得,价格便宜;所使用的设备也均为化工常用设备,操作简单,粗品总收率为38%~46%。In the reaction process of the present invention, no toxic compounds are used or produced, and the environmental pollution is small; the raw materials are easy to obtain and the price is cheap; the equipment used is also common chemical equipment, and the operation is simple, and the total yield of the crude product is 38 %~46%.
附图说明 Description of drawings
图1为本发明所得产品联苯乙酸的红外光谱图;Fig. 1 is the infrared spectrogram of product felbinac obtained from the present invention;
图2为本发明所得产品1H核磁共振谱图;Fig. 2 is gained product of the present invention 1H nuclear magnetic resonance spectrogram;
图3为本发明所得产品13C核磁共振谱图。Fig. 3 is the 13 C nuclear magnetic resonance spectrum of the product obtained in the present invention.
具体实施方式 Detailed ways
下面通过实例进一步说明本发明,但是本发明不仅仅如此。The present invention is further illustrated below by examples, but the present invention is not limited thereto.
实施例1:Example 1:
(1)制备联苯氯甲烷(1) Preparation of biphenyl chloride
在250ml三口烧瓶上通过连接管装有温度计、机械搅拌器、导气管,回流冷凝管,依次加入联苯15.4g(0.1mol),甲醛8.3g(0.1mol),磷酸34.5g(0.3mol)、醋酸18.75g(0.3mol)、浓盐酸25ml。于电子调温加热套上加热至80~90℃,剧烈搅拌18~24小时,每隔30分钟向反应溶液通入HCl气体,氯化氢气体的流量是45L/h。停止反应,冷却至15℃以下,析出固体。减压过滤,滤饼洗涤两次,每次约40ml水,再用20ml 5%的K2CO3溶液洗涤一次。抽干滤饼,转入250ml分液漏斗中,加入40ml乙醚和10ml 5%的K2CO3溶液,振荡,静置,分去碱液层,乙醚层加入无水碳酸钾20g放置24小时进行干燥。蒸去乙醚,将得到的粗产品用环己烷重结晶1次。产品真空干燥。得产品18.27g,纯度为83.62%,该步收率为75.4%。On the 250ml three-necked flask, a thermometer, a mechanical stirrer, an air guide tube, and a reflux condenser were installed through a connecting pipe, and 15.4g (0.1mol) of biphenyl, 8.3g (0.1mol) of formaldehyde, 34.5g (0.3mol) of phosphoric acid, Acetic acid 18.75g (0.3mol), concentrated hydrochloric acid 25ml. Heat to 80-90°C on an electronic temperature-adjusting heating mantle, stir vigorously for 18-24 hours, and feed HCl gas into the reaction solution every 30 minutes. The flow rate of hydrogen chloride gas is 45L/h. The reaction was stopped, cooled to below 15°C, and solids were precipitated. Filter under reduced pressure, wash the filter cake twice, each time with about 40ml of water, and then wash once with 20ml of 5% K 2 CO 3 solution. Drain the filter cake, transfer it to a 250ml separatory funnel, add 40ml ether and
(2)制备联苯乙酸(2) preparation of felbinac
在装有冷凝器(顶端附有氯化钙干燥管)、温度计及常压滴液漏斗的250ml三口烧瓶中,加入镁屑2.4g(0.1mol),碘晶0.2g(0.002mol)。量取90ml乙醚,倒入适量乙醚刚好覆盖镁屑,剩余乙醚溶解上一步所得的联苯氯甲烷于常压滴液漏斗中待用。加入3ml溴乙烷引发反应,碘晶颜色消失后缓缓滴加氯甲基联苯的乙醚溶液,滴加过程用冷水浴维持反应有少量回流。滴加完毕,滴液漏斗用10ml乙醚冲洗,室温搅拌15分钟后,35℃回流2小时。反应完毕,用冰水浴冷却至8℃以下,通入CO2气体2~3小时。完毕,往反应液中加入适量冰块,滴加10%稀盐酸至酸性。蒸馏除去乙醚,减压过滤,洗涤滤饼,抽干。将滤饼转入烧杯中,加入80ml 8%NaOH溶液,加热到80℃溶解,冷却到室温,得白色混浊溶液,减压过滤,收集滤液;滤饼再按上面的操作重复两遍。合并收集到的滤液,加入20%的盐酸酸化,析出白色胶体。减压过滤,干燥,得白色鳞片状固体8.80g,熔点为158~161℃,联苯乙酸粗品总收率为41.9%。In a 250ml three-necked flask equipped with a condenser (with a calcium chloride drying tube attached to the top), a thermometer and an atmospheric dropping funnel, add 2.4g (0.1mol) of magnesium chips and 0.2g (0.002mol) of iodine crystals. Measure 90ml of ether, pour in an appropriate amount of ether just to cover the magnesium chips, and dissolve the remaining ether to dissolve the biphenyl chloride methane obtained in the previous step and put it in an atmospheric dropping funnel for use. Add 3ml of bromoethane to initiate the reaction. After the iodine crystal color disappears, slowly add the ether solution of chloromethylbiphenyl dropwise. During the dropwise addition, use a cold water bath to maintain the reaction with a small amount of reflux. After the dropwise addition was completed, the dropping funnel was rinsed with 10 ml of ether, stirred at room temperature for 15 minutes, and then refluxed at 35° C. for 2 hours. After the reaction is complete, cool down to below 8°C with an ice-water bath, and pass CO 2 gas for 2 to 3 hours. After completion, an appropriate amount of ice cubes was added to the reaction solution, and 10% dilute hydrochloric acid was added dropwise until acidic. Ether was distilled off, filtered under reduced pressure, the filter cake was washed, and drained. Transfer the filter cake into a beaker, add 80ml of 8% NaOH solution, heat to 80°C to dissolve, cool to room temperature to obtain a white turbid solution, filter under reduced pressure, and collect the filtrate; repeat the above operation twice for the filter cake. The collected filtrates were combined, acidified by adding 20% hydrochloric acid, and a white colloid was precipitated. It was filtered under reduced pressure and dried to obtain 8.80 g of a white scaly solid with a melting point of 158-161° C. and a total yield of crude felbinac of 41.9%.
(3)联苯乙酸精制(3) Refined felbinac
上述联苯乙酸粗品用50%乙酸进行重结晶,得联苯乙酸纯品5.52g,含量99.74%,熔点163~165℃,该步收率为62.7%。The crude product of felbinac was recrystallized with 50% acetic acid to obtain 5.52 g of pure felbinac, with a content of 99.74%, a melting point of 163-165°C, and a yield of 62.7%.
实施例2:Example 2:
(1)制备联苯氯甲烷同实施例1。(1) Preparation of diphenylchloromethane is the same as in Example 1.
(2)在装有冷凝器(顶端附有氯化钙干燥管)、温度计及常压滴液漏斗的250ml三口烧瓶中,加入镁屑2.4g(0.1mol),碘晶0.2g(0.002mol)。量取90ml四氢呋喃,倒入适量四氢呋喃刚好覆盖镁屑,剩余四氢呋喃溶解上一步所得的联苯氯甲烷于常压滴液漏斗中待用。其它同上步。得联苯乙酸粗品9.7克,粗品总收率为45.6%。(2) In a 250ml three-neck flask equipped with a condenser (with a calcium chloride drying tube attached to the top), a thermometer and an atmospheric dropping funnel, add 2.4g (0.1mol) of magnesium chips and 0.2g (0.002mol) of iodine crystals. . Measure 90ml of tetrahydrofuran, pour an appropriate amount of tetrahydrofuran just to cover the magnesium chips, and dissolve the remaining tetrahydrofuran with the biphenyl chloride methane obtained in the previous step, and put it in the normal pressure dropping funnel for use. Others are the same as above. 9.7 grams of felbinac crude product were obtained, and the total yield of the crude product was 45.6%.
(3)联苯乙酸精制同实施例1,用70%乙酸进行重结晶,得联苯乙酸纯品5.78g,含量99.79%,熔点163~165℃,该步收率为59.5%。(3) The refinement of felbinac was the same as that in Example 1. Recrystallization was carried out with 70% acetic acid to obtain 5.78 g of pure felbinac, with a content of 99.79%, a melting point of 163-165° C., and a yield of 59.5 percent in this step.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710052668A CN101143815B (en) | 2007-07-09 | 2007-07-09 | The preparation method of felbinac |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710052668A CN101143815B (en) | 2007-07-09 | 2007-07-09 | The preparation method of felbinac |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101143815A true CN101143815A (en) | 2008-03-19 |
CN101143815B CN101143815B (en) | 2010-05-19 |
Family
ID=39206570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200710052668A Expired - Fee Related CN101143815B (en) | 2007-07-09 | 2007-07-09 | The preparation method of felbinac |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101143815B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102503805A (en) * | 2011-10-26 | 2012-06-20 | 上海图帕医药科技有限公司 | Method for preparing 4-felbinac through rearrangement reaction |
CN103086875A (en) * | 2013-02-01 | 2013-05-08 | 山东省医药工业研究所 | Synthetic method of felbinac non-steroidal anti-inflammatory agent |
CN106431911A (en) * | 2016-09-28 | 2017-02-22 | 黄石市利福达医药化工有限公司 | Preparation and purification methods of 4-biphenylacetic acid |
CN110028403A (en) * | 2019-04-19 | 2019-07-19 | 四川大学 | A kind of method of synthesizing succinic acid class compound |
CN111574354A (en) * | 2020-06-18 | 2020-08-25 | 安徽鼎旺医药有限公司 | Biphenylacetic acid and preparation method thereof |
CN116063153A (en) * | 2021-10-29 | 2023-05-05 | 中国科学院大连化学物理研究所 | A kind of synthetic method of 4-biphenylmethanol |
-
2007
- 2007-07-09 CN CN200710052668A patent/CN101143815B/en not_active Expired - Fee Related
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102503805A (en) * | 2011-10-26 | 2012-06-20 | 上海图帕医药科技有限公司 | Method for preparing 4-felbinac through rearrangement reaction |
CN102503805B (en) * | 2011-10-26 | 2013-11-13 | 上海图帕医药科技有限公司 | Method for preparing 4-felbinac through rearrangement reaction |
CN103086875A (en) * | 2013-02-01 | 2013-05-08 | 山东省医药工业研究所 | Synthetic method of felbinac non-steroidal anti-inflammatory agent |
CN106431911A (en) * | 2016-09-28 | 2017-02-22 | 黄石市利福达医药化工有限公司 | Preparation and purification methods of 4-biphenylacetic acid |
CN106431911B (en) * | 2016-09-28 | 2021-05-28 | 黄石市利福达医药化工有限公司 | Preparation and purification method of 4-felbinac |
CN110028403A (en) * | 2019-04-19 | 2019-07-19 | 四川大学 | A kind of method of synthesizing succinic acid class compound |
CN110028403B (en) * | 2019-04-19 | 2020-08-11 | 四川大学 | A kind of method of synthesizing succinic acid compounds |
CN111574354A (en) * | 2020-06-18 | 2020-08-25 | 安徽鼎旺医药有限公司 | Biphenylacetic acid and preparation method thereof |
CN116063153A (en) * | 2021-10-29 | 2023-05-05 | 中国科学院大连化学物理研究所 | A kind of synthetic method of 4-biphenylmethanol |
CN116063153B (en) * | 2021-10-29 | 2025-03-14 | 中国科学院大连化学物理研究所 | A kind of synthetic method of 4-biphenylmethanol |
Also Published As
Publication number | Publication date |
---|---|
CN101143815B (en) | 2010-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101143815B (en) | The preparation method of felbinac | |
CN102311355A (en) | Preparation method of rofecoxib | |
CN102101830A (en) | Method for preparing trinexapac-ethyl | |
CN101671352A (en) | Method for preparing fluoride-bearing phenyloboric acid | |
CN108947861A (en) | The synthetic method of C14H10Cl2NNaO2 | |
CN100999483B (en) | Preparation process of p-nitro phenyl hydrazine hydrochloride | |
CN101265269A (en) | A kind of preparation method of pentafluorophenylboronic acid | |
CN116063153B (en) | A kind of synthetic method of 4-biphenylmethanol | |
CN101503365B (en) | Preparation of venlafaxine intermediate 1-[2-amino-1-(4-methoxy phenyl)ethyl] cyclohexanol | |
CN101665407B (en) | Preparation method of 2,4,5-trifluorobenzyl chloride | |
CN100500648C (en) | A kind of synthetic method of nitrophenol nitrile | |
CN102372687A (en) | Production method for spirodiclofen | |
CN102010325A (en) | Method for synthesizing p-hydroxyphenylacetic acid | |
CN101265201B (en) | A kind of synthetic method of tramadol hydrochloride | |
CN103044356A (en) | New method for synthesizing levocetirizine and key intermediate thereof | |
CN101607868B (en) | Method for synthesizing liquid crystal material intermediate having methlcyclohexanol structure | |
CN101397247B (en) | Indan-1-carboxylic acid synthesis method of bulk drug for clidanic acid | |
CN116102397B (en) | Flurbiprofen Process for the preparation of a compound containing a compound selected from the group consisting of | |
CN102351726A (en) | Method for synthesizing hydrochloric acid baclofen | |
CN103086894A (en) | Synthesis method of electroplating additive 3-methyl-3-aminobutyne | |
CN110256196A (en) | The one-pot synthesis method of D, L- body naproxen | |
CN101972615B (en) | Glycosyl-contained surface active agent as well as preparation method and measuring method thereof | |
CN110642689A (en) | A kind of 3,6-dibromo-2-methylbenzaldehyde and chemical synthesis method thereof | |
CN104628555B (en) | A kind of synthetic method of pharmaceutical intermediate 4-(4-chlorphenyl) cyclohexyl-1-formic acid | |
CN101671267A (en) | Method for directly converting addition product of sodium bisulfite of aldehyde or aliphatic methyl ketone into corresponding oxime |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Yongan Pharmaceutical Co., Ltd., Qianjiang Assignor: Wuhan Institute of Technology Contract record no.: 2011420000184 Denomination of invention: Preparation of non-steroidal anti-inflammatory medicine biphenylacetic acid Granted publication date: 20100519 License type: Exclusive License Open date: 20080319 Record date: 20110714 |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100519 Termination date: 20140709 |
|
EXPY | Termination of patent right or utility model |